Skip to main content
  • COAPT Post-Approval Study Shows Safety, Effectiveness of M-TEER with MitraClip

    The largest real-world prospective outcome study to date, including 5,000 consecutive heart failure (HF) patients with secondary mitral regurgitation (SMR), reinforces the safety and effectiveness of transcutaneous edge-to-edge repair (TEER) using the MitraClip System (Abbott).

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details